San Diego, CA – Tandem Diabetes Care, a leading insulin delivery and diabetes technology company, has announced the launch of updated t:slim X2™ insulin pump software featuring integration with Dexcom G7 Continuous Glucose Monitoring (CGM) in the United States. Tandem’s highly rated automated insulin delivery (AID) system* with Control-IQ technology now stands as the sole AID option globally utilizing Dexcom’s latest CGM technology.
The in-warranty t:slim X2 users in the United States, numbering over 300,000, will receive email instructions, enabling them to add the new Dexcom G7 integration feature free of charge through a remote software update. Meanwhile, t:slim X2 pumps pre-loaded with the updated software have commenced shipping to new customers.
The integration with Dexcom G7 opens up new possibilities for t:slim X2 insulin pump users, allowing them to spend more time in a closed loop with minimal wait time between Dexcom G7 CGM sensor sessions. Additionally, users can opt for either a Dexcom G6 or Dexcom G7 CGM sensor, providing more flexibility in diabetes management....READ MORE
San Diego, CA – Tandem Diabetes Care, a leading insulin delivery and diabetes technology company, has announced the launch of updated t:slim X2™ insulin pump software fea...
A virtual marketplace leading your business into the future
